DSpace logo

Department of Pharmacy : [960] Collection home page

Browse
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 761 to 780 of 960
Issue DateTitleAuthor(s)
2016-06Epigenetic modifications by inhibiting histone deacetylases reverse memory impairment in insulin resistance induced cognitive deficit in miceTaliyan, Rajeev
2015Targeting Histone Deacetylases: A Novel Approach in Parkinson’s DiseaseTaliyan, Rajeev
2015Histone Deacetylase Inhibitor, Trichostatin A, Improves Learning and Memory in High-Fat Diet-Induced Cognitive Deficits in MiceTaliyan, Rajeev
2021Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBBTaliyan, Rajeev
2016-11Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetesTaliyan, Rajeev
2015-09Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activityTaliyan, Rajeev
2019Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent quorum sensing in Pseudomonas aeruginosaMurugesan, Sankaranarayanan
2020Screening Marine Natural Products for New Drug Leads against Trypanosomatids and MalariaMurugesan, Sankaranarayanan
2020-02Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapyMurugesan, Sankaranarayanan
2020-05Design, synthesis, α-amylase inhibition and in silico docking study of novel quinoline bearing proline derivativesMurugesan, Sankaranarayanan
2020-06A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discoveryMurugesan, Sankaranarayanan
2020-07Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agentsMurugesan, Sankaranarayanan
2020Leishmaniasis is the most widespread pathogenic disease in several countries. Currently, no effective vaccines are available, and the control of Leishmaniasis primarily relies on decade-old chemotherapy. The treatment for the Leishmaniasis is not up to the mark. Current therapy for Leishmaniasis is ancient and requires hospitalization for the administration. These medications are also highly toxic and resistant. β-carboline, a natural indole containing alkaloid, holds a vital position in the field of medicinal chemistry with a diversified pharmacological action. The current review focuses mainly on the anti-leishmanial effects of β-carboline analogs and their synthetic strategies, structural activity relationship studies (SAR). The past ten years alterations unveiled by β-carboline analogs present in phytoconstituents and various derivatives of synthesized analogs with the mechanism of action were briefly shortlisted and illustratedMurugesan, Sankaranarayanan
2020-09Review article| Volume 6, ISSUE 9, e04916, September 2020 PDF [2 MB] Figures Save Share Reprints Request Recent evolution on synthesis strategies and anti-leishmanial activity of β-carboline derivatives – An updateMurugesan, Sankaranarayanan
2020Coumarin-Oxadiazole Derivatives: Synthesis and Pharmacological PropertiesMurugesan, Sankaranarayanan
2020-10Synthesis, biological evaluation, molecular docking, molecular dynamics and DFT studies of quinoline-fluoroproline amide hybridsMurugesan, Sankaranarayanan
2020-07Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activitiesMurugesan, Sankaranarayanan
2020-11Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19Murugesan, Sankaranarayanan
2020Sequential multicomponent catalytic synthesis of pyrrole-3-carboxaldehydes: Evaluation for antibacterial and antifungal activities along with docking studiesMurugesan, Sankaranarayanan
2020Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agentsMurugesan, Sankaranarayanan
Collection's Items (Sorted by Submit Date in Descending order): 761 to 780 of 960